Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...

For Series A, some differences emerge. The median size for Utilities, Food & Beverage, Household Goods and Agriculture was $3 ...

V, a new, modular, and scalable gripper system for robotics, designed to handle workpieces of various sizes and shap ...

Nuveen Churchill Direct Lending posted solid 2024 results, growing net & total investment income YoY despite a slight ...

FM:Systems today announced the integration of its flagship workplace management solution, FMS:Workplace with Johnson Controls Metasys building automation system. The integration allows for rapid ...

CDMO, has appointed Dr James Miskin as Non-Executive Director. James brings extensive experience in the cell and gene therapy sector, following a 23-year tenure at Oxford Biomedica. He oversaw ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, ...

The equity financing is at a 10% premium to the market share price1 ZÜRICH, SWITZERLAND / ACCESS Newswire / March 31, 2025 / NLS Pharmaceutics Ltd.(NASDAQ:NLSP) ("NLS" or the "Company"), a Swiss clini ...

European markets are expected to open lower Monday as global markets await U.S. President Donald Trump’s previously announced ...

Guo Guangchang, Chairman of Fosun International Limited (HKEX: 0656), issued a letter to its shareholders on 30 March, outlining the Company's strategic direction, accomplishments, and future plans.

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...

RIPSA interests repurchased Term loan facility increased to $450 million with more favorable terms Access to up to an additional $200 million LONDON and RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) ...